Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3
NCT ID: NCT06010121
Last Updated: 2023-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2023-02-17
2023-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetic Analysis of Nutrient Absorption From a Novel Liposomal Multivitamin/Mineral Formulation
NCT05060367
Lipoic Acid and Prevention of Heart Disease
NCT00765310
Lipid-lowering Effect of Plant Stanol Drink
NCT01716390
LIP-01 in Hypercholesterolemia
NCT00966225
Lipid Lowering Effect of Plant Stanol Ester in a Spoonable Non-dairy Product
NCT05064644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liposomal Vitamin D
Daily oral dose of liposomal vitamin D for 4 weeks
Liposomal Vitamin D
2000 IU of cholecalciferol in liposomal formulation
Traditional Vitamin D
Daily oral dose of traditional vitamin D for 4 weeks
Traditional Vitamin D
2000 IU of cholecalciferol in traditional formulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liposomal Vitamin D
2000 IU of cholecalciferol in liposomal formulation
Traditional Vitamin D
2000 IU of cholecalciferol in traditional formulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent.
* No injuries or hospitalizations within the last 3 months.
* No vitamin D supplementation for the 2 months prior to the study initiation.
* Refraining for the period of the clinical trial from consuming foods additionally fortified with vitamin D and dietary supplements containing vitamin D
* Refraining for the period of the clinical trial from the use of cosmetic therapies that use prolonged body illumination
Exclusion Criteria
* Injuries within the last 3 months
* Obesity, BMI above 30
* Bariatric surgery
* Cystic fibrosis, celiac disease, Crohn's disease
* Metabolic diseases
* Drugs reducing cholesterol absorption, thiazide diuretics, glucocorticosteroids, anticonvulsants, calcium-containing preparations,
* Planned prolonged exposure to sunlight during the study period
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AronPharma Sp. z o. o.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gdański Uniwersytet Medyczny
Gdansk, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-AP-VD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.